Finally, inter-individual variations in the development of irAEs for the same cancer and the same ICI regimen suggest an additional genetic background [15] with a predisposition to autoimmunity (i.e., CTLA-4 and PDL-1 polymorphisms that are associated with autoimmune disorders [60,61]. Here, CTLA4 is linked to Autoimmunity.